Ann: Press Article Correction, page-34

I have been watching BOT for a little while and will buy in at some stage.
Good prospects for a ~70m company.

However, I am confused today.
They actually said that the market shares & sales forecasts were based on nothing and retracted them.
They went as far as to say that did not have a reasonable basis for making such forecasts.

The other comments about pfizer etc. Why would they comment one way or the other on them.
It wasn't part of the article.

I expected the correction should have sent the sp down, not up.
I think some people were just not watching close enough and got caught out.
Will be waiting to buy in at a lower price.

GLTAH I think BOT has a great future, just not on this.

"The slide also sets out various scenarios for potential market share and corresponding potential
gross sales. To the extent that these scenarios could be considered a financial forecast, Botanix
retracts the scenarios and examples sales figures given. Botanix does not have a reasonable basis for
making a sales forecast at this stage."